Request Demo
Last update 01 Apr 2025
Pharmathen SA
Last update 01 Apr 2025
Overview
Basic Info
Introduction Pharmathen SA is a pharmaceutical company that specializes in the development, production, and marketing of various medications. Their product line includes a diverse range of drugs such as a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. Established in 1969, Pharmathen SA is headquartered in Pallini, Greece. |
Tags
Cardiovascular Diseases
Nervous System Diseases
Other Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTRI/2024/09/074455
An Open-Label, Multiple Dose, Multicenter, Randomized, Two Sequence, Two-Treatment, fully Replicate, Cross-Over, Steady State, Bioequivalence Study of Test Product Leuprolide Acetate for Depot Suspension 7.5 mg of Pharmathen S.A. Greece with Reference Product Lupron Depot® 7.5 mg, Manufactured for AbbVie Inc. in Adult Male Patients with Prostate Carcinoma Undergoing Initial Therapy of Leuprolide Acetate. - NIL
CTRI/2023/09/057619
An open label, multicenter, balanced, randomized, parallel, three-treatment, three arm, single-period, single dose comparative bioavailability study of Leuprolide acetate for depot suspension 30 mg for 4-month administration of Pharmathen S.A., Greece, with LUPRON DEPOT (Leuprolide Acetate for Depot Suspension) 30 mg for 4-month administration of AbbVie Inc. North Chicago, IL 60064 in adult male subjects with prostatic cancer undergoing initial therapy of leuprolide acetate 30 mg under fasting conditions. - 22-VIN-0466
CTRI/2022/02/040103
A Randomized, Open Label, Multicenter, Two-treatment, Single-period, Multiple Dose, Parallel, Steady State Bioequivalence Study of Paliperidone Palmitate (3-month) Extended Release Injectable Suspension for intramuscular use 546 mg (350 mg Paliperidone) (Pharmathen S.A., Greece) compared to TREVICTA�® 350 mg Prolonged Release Suspension for injection (Janssen-Cilag International NV, Belgium) in adult schizophrenic patients.
100 Clinical Results associated with Pharmathen SA
Login to view more data
Login to view more data
100 Deals associated with Pharmathen SA
Login to view more data
100 Translational Medicine associated with Pharmathen SA
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 26 Apr 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
3
3
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free